Lmr Partners LLP Aclaris Therapeutics, Inc. Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$17.08 - $29.6 $460,715 - $798,430	-26,974 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$5.86 - $27.73 $158,067 - $747,989	26,974 New	26,974 $680,000
Q4 2020 Feb 16, 2021	SELL	$2.65 - $7.61 $30,263 - $86,906	-11,420 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.5 - $2.71 $3,022 - $5,460	-2,015 Reduced 15.0%	11,420 $29,000
Q2 2020 Aug 14, 2020	BUY	$1.04 - $1.73 $13,972 - $23,242	13,435 New	13,435 $22,000

50.7M

30.6K

Ticker ACRS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 66,671,800
Market Cap $242M
Description
Aclaris Therapeutics, Inc. operates a clinical-stage biopharmaceutical company, develops novel drug candidates for immune-inflammatory diseases in the United States. It operates through two segments: Therapeutics and Contract Research. The Therapeutics segment is involved in identifying and developing innovative therapies to address significant ...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.